Study of Cingal® and Triamcinolone Hexacetonide for the Relief of Knee Osteoarthritis Pain
Trial details
- Registry ID
- NCT04231318
- Phase
- Phase 3
Drug identity checked against registry records
Also recorded as TH
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| Study of Cingal® and Triamcinolone Hexacetonide for the Relief of Knee Osteoarthritis PainNCT04231318 | ANIK | Phase 3 | Completed | 2022-05-16Actual |
| No regulatory events match this view.This does not mean no FDA events have occurred. |